We are excited to announce to you the biological molecule of interest for SensUs 2019 competition!

This years molecule for detection will be Etanercept.

Etanercept is a fusion protein that is found in the body after breakdown of the pharmaceutical drug necessary to treat Rheumatoid Arthritis (RA) or Rheumatic disease. It works by inhibiting TNF-alpha (Tumor Necrosis Factor-alpha), which is a key regulator in inflammatory immune response.

Rheumatoid arthritis is currently stated to affect over 120 million people (at least a quarter of a million people) on World Arthritis Day. It is a painful autoimmune disease causing inflammation and joint pain.

Our goal for this upcoming year is to build a device that can help patients and providers better manage Rheumatoid Arthritis (along with other inflammatory autoimmune diseases). And help improve their quality of life.

Here  is a short video about it so you can learn more. We hope you will join us in the fight to help patients that are living with inflammatory autoimmune disease.


No responses yet

Leave a Reply

Your email address will not be published. Required fields are marked *